bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
All Web sites
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2014: A M F J
2013: D N O S A J J M A

  FDA OKs Injections to Treat Curvature of Penis
Previously, surgery was the only approved treatment for Peyronie's disease

By Robert Preidt

FRIDAY, Dec. 6, 2013 (HealthDay News) -- The first drug treatment for unusual curvature of the penis has been approved by the U.S. Food and Drug Administration, the agency announced Friday.

Men with the condition, called Peyronie's disease, have a lump in the penis that causes curvature of at least 30 degrees during an erection. The disorder, which is caused by scar tissue under the skin of the penis, can cause bothersome symptoms during sex.

Until now, surgery was the only medical option for men with the condition, according to an FDA news release.

The FDA's approval of the drug Xiaflex (collagenase clostridium histolyticum) to help men with Peyronie's disease calls for a maximum of four treatment cycles. Each cycle consists of two injections and one penile remodeling procedure performed by a health care professional.

The approval is based on two studies involving more than 800 men with Peyronie's disease. Men who received the drug had significant reductions in penile curvature and related bothersome effects, compared to those who were given an inactive placebo.

The most common side effects associated with the use of Xiaflex are swelling and pain in the penis. There is a risk for serious problems, including penile fracture, and the drug should be given by a health care professional with experience in treating male urological diseases, the FDA said.

Xiaflex was first approved by the FDA in 2010 to treat Dupuytren's contracture, a progressive hand disease that can affect a person's ability to straighten and use their fingers.

The drug is believed to work for Peyronie's disease by breaking down the buildup of collagen (a structural protein in connective tissue) that causes the deformity in the penis, the FDA explained.

The drug is marketed by Pennsylvania-based Auxilium Pharmaceuticals, Inc.

More information

The U.S. National Kidney and Urologic Diseases Information Clearinghouse has more about Peyronie's disease.

SOURCE: U.S. Food and Drug Administration, news release, Dec. 6, 2013

Copyright © 2013 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=682855

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Penis
Men
Therapeutics
Tissues
Urologic Diseases
Affect
Contracture
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact